Mixing Pfizer, AstraZeneca COVID-19 shots with Moderna gives better immune response: UK study

Mixing Pfizer, AstraZeneca COVID-19 shots with Moderna gives better immune response: UK study

7/12/2021 3:36:00 AM

Mixing Pfizer, AstraZeneca COVID-19 shots with Moderna gives better immune response: UK study

LONDON: A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots followed by Moderna nine weeks later, according to the results on Monday (Dec 6). \u0022We found a really good immune response ac

LONDON: A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots followed by Moderna nine weeks later, according to the results on Monday (Dec 6).

You Must Definitely Watch! Here is Funny and Desperate That Moments

"We found a really good immune response across the board ..., in fact, higher than the threshold set by Oxford-AstraZeneca vaccine two doses," Matthew Snape, the Oxford professor behind the trial dubbed Com-COV2, told Reuters.The findings supporting flexible dosing will offer some hope to poor and middle income countries which may need to combine different brands between first and second shots if supplies run low or become unstable.

"I think the data from this study will be especially interesting and valuable to low- and middle-income countries where they're still rolling out the first two doses of vaccines," Snape said."We're showing ... you don't have to stick rigidly to receiving the same vaccine for a second dose ... and that if the programme will be delivered more quickly by using multiple vaccines, then it is okay to do so." headtopics.com

If the AstraZeneca-Oxford vaccine is followed by a Moderna or Novavax shot, higher antibodies and T-cell responses were induced versus two doses of AstraZeneca-Oxford, according to researchers at the University of Oxford.The study of 1,070 volunteers also found that a dose of the Pfizer-BioNTech vaccine followed by a Moderna shot was better than two doses of the standard Pfizer-BioNTech course.

Father in China donates organs of daughter, 9, who died from brain damage after classmate pushed her

Pfizer-BioNTech followed by Novavax induced higher antibodies than the two-dose Oxford-AstraZeneca schedule, although this schedule induced lower antibody and T-cell responses than the two-dose Pfizer-BioNTech schedule.No safety concerns were raised, according to the Oxford University study published in the Lancet medical journal.

Many countries have been deploying a mix and match well before robust data was available as nations were faced with soaring infection numbers, low supplies and slow immunisation over some safety concerns.Longevity of protection offered by vaccines has been under scrutiny, with booster doses being considered as well amid surging cases. New variants, including Delta and Omicron, have now increased the pressure to speed up vaccination campaigns.

Related:Commentary: Vaccine effects don't last forever, that's why we have boostersBlood samples from participants were tested against the Wild-Type, Beta and Delta variants, researchers of the Com-COV2 study said, adding that vaccines' efficacy against the variants had waned, but this was consistent across mixed courses. headtopics.com

Parents send off BMT recruits in-person at Pulau Tekong for first time in 2 years

Deploying vaccines using technology from different platforms - like Pfizer and Moderna's mRNA, AstraZeneca's viral vector and Novavax's protein-based shot - and within the same schedule is new.The results may inform new approaches to immunisation against other diseases, he said.

The study also found that a first dose of the AstraZeneca-Oxford vaccine followed by any of the other candidates in the study generated a particularly robust response, consistent with findings in June.The study was designed as a so-called"non-inferiority" study – the intent is to demonstrate that mixing is not substantially worse than the standard schedules - and compares the immune system responses to the gold-standard responses reported in previous clinical trials of each vaccine.

Read more: CNA »

Young anglers spreading message of sustainable fishing through social media and workshops

SINGAPORE — In a minute-long clip on social media platform TikTok, a presenter explains why it is okay to catch and keep hybrid groupers caught in Singapore waters.

Jmm gggjffjfhf

South Africa's Biovac to start making Pfizer-BioNTech COVID-19 vaccine in early 2022KIGALI: South Africa\u0027s Biovac Institute will start making Pfizer-BioNTech\u0027s COVID-19 vaccine early next year after receiving the drug substance from facilities in Europe, a Pfizer executive said on Monday (Dec 6). That earlier than the forecast start at around the second half of 2022 given by Cape Town-bas

Australia's medicine regulator approves Pfizer vaccine for children aged 5 to 11MELBOURNE: Australia\u0027s medicine regulator provisionally approved on Sunday (Dec 5) the Pfizer coronavirus vaccine for children between the ages of 5 and 11, with the health minister saying the rollout could begin from Jan 10. \u0022They (the Therapeutics Goods Administration) have made a careful, thor , I'm M y u BB uhh be avvt K vy boK

South Africa's Biovac to start making Pfizer-BioNTech COVID-19 vaccine in early 2022KIGALI: South Africa\u0027s Biovac Institute will start making Pfizer-BioNTech\u0027s COVID-19 vaccine early next year after receiving the drug substance from facilities in Europe, a Pfizer executive said on Monday (Dec 6). That earlier than the forecast start at around the second half of 2022 given by Cape Town-bas

UBS gives Hong Kong staff COVID-19 quarantine cashHONG KONG: UBS Group has offered its Hong Kong staff up to HK$2,000 (US$256.45) a day to help cover mandatory hotel quarantine costs as the city maintains some of the strictest COVID-19 restrictions in the world. In a memo seen by Reuters, the bank said full-time employees up to executive director level wo

MOM: Non-Malaysian work permit or S pass holders in CMP sectors can no longer enter S’pore via VLT - The Independent Singapore NewsIn response to the Omicron Covid-19 variant, Singapore announced on Friday stricter rules for VTL travellers. in responed 2 all inquiree..i believd izs fair MOM hab 2 take such steps in d domitree issues..